A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza VaccinesNeal Van Hoeven, Darrick Carter, Sharvari Waghmare Joshi et al.|Scientific Reports|2017Cited by 86